Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02987725 · ClinicalTrials.gov registry record · NA
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02987725 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 25 participants.
The verdict
NCT02987725, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effects of a laboratory-based hypnosis session compared to an attention control condition on peripheral blood flow, autonomic stress responses, and acute pain responses in adolescents (ages 12-21) with sickle cell disease, and examine how perceived disease-related stigma may affect these responses.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Hypnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02987725
The ClinicalTrials.gov registry entry for NCT02987725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT02987725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02987725 about?
NCT02987725 is a clinical study titled "Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease". The purpose of this study is to test the effects of a laboratory-based hypnosis session compared to an attention control condition on peripheral blood flow, autonomic stress responses, and acute pain responses in adolescents (ages 12-21) with sickle cell disease, and examine how perceived disease-re...
What is the current status of trial NCT02987725?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-03-16. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT02987725?
The interventions under investigation include: Attention Control (BEHAVIORAL), Hypnosis (BEHAVIORAL).
Who is sponsoring clinical trial NCT02987725?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.